Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study

AIM: To investigate the safety and efficacy of S-1 plus oxaliplatin (SOX) as an adjuvant chemotherapy regimen in gastric cancer (GC) after D2 dissection. METHODS: GC Patients who underwent D2 gastrectomy from September 2009 to December 2011 in four Chinese institutions were enrolled. Patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Deng-Feng, Zheng, Fang-Chao, Zhao, Jun-Hui, Shen, Guo-Shuang, Ahmad, Raees, Zhang, Shui-Sheng, Zhang, Yu, Kan, Jie, Dong, Li, Wang, Zi-Yi, Zhao, Fu-Xing, Zhao, Jiu-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163137/
https://www.ncbi.nlm.nih.gov/pubmed/30283800
http://dx.doi.org/10.12998/wjcc.v6.i10.373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163137/
https://www.ncbi.nlm.nih.gov/pubmed/30283800
http://dx.doi.org/10.12998/wjcc.v6.i10.373

Ejemplares similares